Patent classifications
A61K36/886
Methods of treatment using decolorized <i>Aloe vera </i>extracts
Provided herein is a method for improving the health of an intestinal epithelial barrier using Aloe vera. The method may include administering Aloe vera extracts to intestinal epithelial cells. The decolorized aloe extract may be whole leaf extract, whole leaf dry extract, inner leaf dry extract, digested whole leaf extract, digested whole leaf dry extract, digested inner leaf dry extract, or a combination thereof.
Methods of treatment using decolorized <i>Aloe vera </i>extracts
Provided herein is a method for improving the health of an intestinal epithelial barrier using Aloe vera. The method may include administering Aloe vera extracts to intestinal epithelial cells. The decolorized aloe extract may be whole leaf extract, whole leaf dry extract, inner leaf dry extract, digested whole leaf extract, digested whole leaf dry extract, digested inner leaf dry extract, or a combination thereof.
Topical compositions comprising extract of <i>Coriolus </i>versicolor for autoimmunity enhancement
The present invention provides a topical composition comprising extract from Coriolus versicolor for use for preventing and/or treating by vaginal or cervical administration of a vaginal or cervical disorder which is caused by an infectious agent, in particular, human papiloma virus infections and related disorders, including cervical cancer. The composition of the invention acts enhancing genital immunity against infectious agents and re-epithelising damaged tissue.
Topical compositions comprising extract of <i>Coriolus </i>versicolor for autoimmunity enhancement
The present invention provides a topical composition comprising extract from Coriolus versicolor for use for preventing and/or treating by vaginal or cervical administration of a vaginal or cervical disorder which is caused by an infectious agent, in particular, human papiloma virus infections and related disorders, including cervical cancer. The composition of the invention acts enhancing genital immunity against infectious agents and re-epithelising damaged tissue.
Compositions for treating infections
Various compositions for treating a skin or mucosal membrane infection contain glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound. The composition contains substantially no water. The glycerol may be at least 31.5% or between about 30% and 80% by weight of the composition, the at least one surfactant may be between about 1% and 10% by weight of the composition, the alcohol may be between about 10% and 50% or between about 20% and 60% by weight of the composition, the terpene or terpenoid compound may be between about 0.5% and 10% by weight of the composition, and the copper compound may be between about 1% and 10% by weight of the composition.
Compositions for treating infections
Various compositions for treating a skin or mucosal membrane infection contain glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound. The composition contains substantially no water. The glycerol may be at least 31.5% or between about 30% and 80% by weight of the composition, the at least one surfactant may be between about 1% and 10% by weight of the composition, the alcohol may be between about 10% and 50% or between about 20% and 60% by weight of the composition, the terpene or terpenoid compound may be between about 0.5% and 10% by weight of the composition, and the copper compound may be between about 1% and 10% by weight of the composition.
Compositions for treating infections
Various compositions for treating a skin or mucosal membrane infection contain glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound. The composition contains substantially no water. The glycerol may be at least 31.5% or between about 30% and 80% by weight of the composition, the at least one surfactant may be between about 1% and 10% by weight of the composition, the alcohol may be between about 10% and 50% or between about 20% and 60% by weight of the composition, the terpene or terpenoid compound may be between about 0.5% and 10% by weight of the composition, and the copper compound may be between about 1% and 10% by weight of the composition.
GALORE HAIR OILS
An improved composition of hair oil for stimulation of hair growth, control of hair fall, dandruff and infections thereof. The composition of hair oil comprising active ingredients of variety of herbs, vitamins, essential oils and Ginseng root. The composition of hair oil supports the hair growth and relaxation of the scalp. The composition of hair oil also effectively reduces/remove dandruff and thereby control hair fall in the subject (e.g., not limiting to male/female human). The composition of hair oil additionally demonstrates the properties of cooling effect, darkening of hair and promotion of hair upon continuous use of the hair oil by the subjects.
GALORE HAIR OILS
An improved composition of hair oil for stimulation of hair growth, control of hair fall, dandruff and infections thereof. The composition of hair oil comprising active ingredients of variety of herbs, vitamins, essential oils and Ginseng root. The composition of hair oil supports the hair growth and relaxation of the scalp. The composition of hair oil also effectively reduces/remove dandruff and thereby control hair fall in the subject (e.g., not limiting to male/female human). The composition of hair oil additionally demonstrates the properties of cooling effect, darkening of hair and promotion of hair upon continuous use of the hair oil by the subjects.
METHOD AND DEVICE FOR THE ENHANCEMENT OF TOPICAL TREATMENTS FOR ORAL MUCOSITIS AND OTHER ORAL CONDITIONS
A method of enhancing absorption of a therapeutic agent sublingually in a person configured to treat chronic graft-versus-host disease (cGVHD) or aphthous stomatitis. The method includes administering a therapeutically effective amount of the therapeutic agent sublingually in a person and then inserting for a predetermined treatment period a device in an oral cavity of the person, wherein the device comprising an oral retention portion that is configured to be retained in the oral cavity from the predetermined treatment period and further configured to enhance absorption of the therapeutic agent sublingually.